Based on the findings that the upregulation of DYRK3 in melanoma skin cancer cells and dysregulation of the mTOR pathway are closely associated with various types of human tumors, we investigated the effect of DYRK3-mediated activation of the mTORC1 pathway on melanoma cancer cell growth. Here, DYRK3 is linked to melanoma.